The Effects of Exercise in Parkinson's Disease
Trial
N/A
Completed
March 16, 2021
Self-motion Perception in Parkinson's Disease
Trial
N/A
Unknown
March 16, 2021
The Learning Effects of Task-priority Strategy on Dual-task Weight Shifting and Brain Plasticity in Patients With Parkinson's Disease
Trial
N/A
Completed
March 16, 2021
Multiple Practice Contexts to Reduce Context-dependent Learning in PD
Trial
N/A
Completed
March 15, 2021
PET Scan to Study Brain Control of Human Movement
Trial
N/A
Completed
March 15, 2021
The Effect of Clinical Pilates Training on Balance and Postural Control of People With Parkinson's Disease.
Trial
N/A
Completed
March 11, 2021
Distribution of Non-Motor Symptoms in Idiopathic Parkinson's Disease and Secondary Parkinsonism
Trial
N/A
Completed
March 11, 2021
Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease
Trial
Phase 2
Completed
March 10, 2021
Effects of PS128 on Parkinsonian Symptoms
Trial
N/A
Completed
March 9, 2021
Buspirone, in Combination With Amantadine, for the Treatment of Levodopa-induced Dyskinesia
Trial
Phase 1
Terminated
March 4, 2021
Multidisciplinary Health Educational Program Based on Centered People Care Model in Parkinson's Disease
Trial
N/A
Unknown
March 4, 2021
Unilateral GPi vs Unilateral STN DBS in the Same Patient With PD
Trial
N/A
Completed
March 3, 2021
Comparative Controlled Study of Analgesic, Antiasthenic and Anti-Anxiety Effects of Xenon in Patients With Parkinson's Disease
Trial
Phase 1
Unknown
March 2, 2021
Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease
Trial
N/A
Completed
March 1, 2021
Nabilone for Non-motor Symptoms in Parkinson's Disease
Trial
Phase 2
Completed
March 1, 2021
Nabilone for Non-motor Symptoms in Parkinson's Disease
Trial
Phase 3
Completed
March 1, 2021
A Study to Determine the Dose of WIN-1001X by Evaluating Efficacy and Safety in Early Parkinson's Disease Patients
Trial
Phase 2
Unknown
Feb. 23, 2021
Dental Appliance for Parkinson's Disease
Trial
N/A
Completed
Feb. 23, 2021
An Exploratory Study Investigating Safety, Tolerability and Pharmacokinetics of Ascending Doses of Lu AE04621 in Parkinson Disease Patients
Trial
Phase 1
Completed
Feb. 23, 2021
Cognitive Rehabilitation for PD
Trial
N/A
Completed
Feb. 22, 2021